Indo US Bio-Tech (BOM:541304) Notes Receivable: ₹0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:541304 Indo US Bio-Tech Ltd BOM:541304
71 GF Score
Price ₹84.00
GF Value ₹314.28
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Indo US Bio-Tech Notes Receivable?

Indo US Bio-Tech BOM:541304 +2.07% 71 Notes Receivable is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:541304 with a GF Score™ of 71/100 and a GF Value™ of ₹314.28 (Possible Value Trap). The stock has 5 warning signs investors should review.

Indo US Bio-Tech's Notes Receivable for the quarter that ended in Mar. 2026 was ₹0 Mil.

Indo US Bio-Tech Notes Receivable Related Terms

Indo US Bio-Tech Notes Receivable Historical Data

* Premium members only.

The historical data trend for Indo US Bio-Tech's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo US Bio-Tech Notes Receivable Chart

Indo US Bio-Tech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Indo US Bio-Tech Quarterly Data
Mar20 Sep20 Mar21 Sep21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:541304
71GF Score
Indo US Bio-Tech Ltd BOM:541304
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo US Bio-Tech Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0 Mil mean?
Indo US Bio-Tech (BOM:541304) has a Notes Receivable of ₹0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Indo US Bio-Tech and its competitors.
Is Indo US Bio-Tech's Notes Receivable too high?
Indo US Bio-Tech's current Notes Receivable is ₹0 Mil. Overall, Indo US Bio-Tech has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's Notes Receivable compare to CTVA and CF?
Indo US Bio-Tech's Notes Receivable of ₹0 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for an Agriculture company?
A good Notes Receivable depends on the Agriculture industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Indo US Bio-Tech and its competitors. Indo US Bio-Tech's current Notes Receivable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (BOM:541304) is currently considered Possible Value Trap. The stock's GF Value™ is ₹314.28, compared to a current price of ₹84.00 — trading 73.3% below its estimated fair value. The current Notes Receivable is ₹0 Mil. Indo US Bio-Tech's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Indo US Bio-Tech (BOM:541304), the current Notes Receivable is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indo US Bio-Tech (BOM:541304) Overvalued in 2026?

Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued. The current stock price of ₹84.00 is trading 73.3% below its estimated GF Value™ of ₹314.28. GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.

Key valuation signals for BOM:541304:

  • Notes Receivable: ₹0 Mil
  • GF Value™: ₹314.28 vs. price of ₹84.00 (73.3% below fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the BOM:541304 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Indo US Bio-Tech Business Description

Other Exchanges INDOUS:India
Address Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
71GF Score

Get the complete analysis for BOM:541304

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹84.00
Price
₹314.28
GF Value